- Home
- TVGN vs EDAP Comparison
TVGN vs EDAP Comparison
Compare TVGN & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- EDAP
- Stock Information
- Founded
- TVGN 2020
- EDAP 1979
- Country
- TVGN United States
- EDAP France
- Employees
- TVGN N/A
- EDAP N/A
- Industry
- TVGN Blank Checks
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TVGN Finance
- EDAP Health Care
- Exchange
- TVGN Nasdaq
- EDAP Nasdaq
- Market Cap
- TVGN 89.3M
- EDAP 75.5M
- IPO Year
- TVGN N/A
- EDAP 1997
- Fundamental
- Price
- TVGN $0.45
- EDAP $2.38
- Analyst Decision
- TVGN Strong Buy
- EDAP Buy
- Analyst Count
- TVGN 1
- EDAP 3
- Target Price
- TVGN $5.00
- EDAP $8.50
- AVG Volume (30 Days)
- TVGN 594.7K
- EDAP 57.2K
- Earning Date
- TVGN 11-14-2025
- EDAP 11-06-2025
- Dividend Yield
- TVGN N/A
- EDAP N/A
- EPS Growth
- TVGN N/A
- EDAP N/A
- EPS
- TVGN N/A
- EDAP N/A
- Revenue
- TVGN N/A
- EDAP $74,853,925.00
- Revenue This Year
- TVGN N/A
- EDAP N/A
- Revenue Next Year
- TVGN N/A
- EDAP N/A
- P/E Ratio
- TVGN N/A
- EDAP N/A
- Revenue Growth
- TVGN N/A
- EDAP 0.61
- 52 Week Low
- TVGN $0.38
- EDAP $1.21
- 52 Week High
- TVGN $1.92
- EDAP $3.05
- Technical
- Relative Strength Index (RSI)
- TVGN 38.49
- EDAP 55.69
- Support Level
- TVGN $0.38
- EDAP $1.95
- Resistance Level
- TVGN $0.47
- EDAP $2.53
- Average True Range (ATR)
- TVGN 0.05
- EDAP 0.17
- MACD
- TVGN 0.00
- EDAP 0.03
- Stochastic Oscillator
- TVGN 27.31
- EDAP 65.49
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.